Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations

Authors :: Fontana, Maria Chiara
Marconi, Giovanni
Milosevic Feenstra, Jelena D.
Papayannidis, Cristina
Manfrini, Marco
Guadagnuolo, Viviana
Simonetti, Giorgia
Padella, Antonella
Ferrari, Anna
Franchini, Eugenia
Ghelli Luserna di Rorà, Andrea
Ottaviani, Emanuela
De Tommaso, Rossella
Bruno, Samantha
Soverini, Simona
Testoni, Nicoletta
Paolini, Stefania
Sartor, Chiara
Parisi, Sarah
Tenti, Elena
Kralovics, Robert
Martinelli, Giovanni
Source :: Blood; December 2016, Vol. 128 Issue: 22 p1678-1678, 1p
Publication Year :: 2016
Abstract: Kralovics: Qiagen: Membership on an entity's Board of Directors or advisory committees; AOP Orphan: Research Funding. Martinelli:Novartis: Speakers Bureau; Amgen: Consultancy, Speakers Bureau; Celgene: Consultancy, Speakers Bureau; MSD: Consultancy; Genentech: Consultancy; Pfizer: Consultancy, Speakers Bureau; Ariad: Consultancy, Speakers Bureau; BMS: Speakers Bureau; Roche: Consultancy, Speakers Bureau.

Full Text Access

Tools